Stay informed with the latest updates for the inheritable blood disorders community.

Industry
NHF-McMasters Guidelines on ECRI
Aptevo Announces Patient-Reported Study Results Related to IXINITY® Use
Medical Advisory
Medical Advisory
Medical Advisory #423: CSL Behring Discontinues Production…
NBDF & Community
Big Finish for Team NHF!
Big Finish for Team NHF!
Medical
HTC Investigators Look at UDC Data on Females with Bleeding Disorders
HTC Investigators Look at UDC Data on Females with Bleeding Disorders
Industry
Hemlibra Safety Update
Novo Nordisk Announces BLA Submission for Extended Half-Life FVIII Therapy…
NBDF & Community
Take the National HTC Patient Satisfaction Survey Today!
Take the National HTC Patient Satisfaction Survey Today!
Ron Bark, 1962-2018
Ron Bark, 1962-2018
NHF Mourns the Loss of Barry Haarde
NHF Mourns the Loss of Barry Haarde
Medical
NHLBI Workshop on Factor VIII Inhibitors is Less Than Two Weeks Away!
NHLBI Factor VIII Inhibitor Workshop Registration Now Open
Peer-Reviewed Journal Summaries
Retrospective Study Reflects Successful Transition to Extended Half-Life Therapies
Retrospective Study Reflects Successful Transition to Extended…
Industry
Genentech Announces Positive HEMLIBRA Trial Results
REBINYN® Now Available for Hemophilia B Patients
Medical
Updates on My Life Our Future Genotyping Project
My Life, Our Future to Be Featured in CDC Public Health Webinar
NBDF & Community
Rare Disease Day Coming to National Institutes of Health in March
Rare Disease Day Coming to National Institutes of Health in March
NBDF & Community
HANDI Highlights Emergency Preparedness Resources to the Community
HANDI Highlights Emergency Preparedness Resources to the Community
Medical
Newly Accredited Provider Webinar for Enhancing Outcomes for Women with Bleeding Disorders
Newly Accredited Provider Webinar for Enhancing Outcomes…